Bayer Investor Relations

A bird's eye view of a building with a logo on it.
News from Bayer
March 04, 2024
Not intended for U.S. and UK Media
Bayer strengthens pharma portfolio with new cardiology drug acoramidis
February 29, 2024
Heiko Schipper to leave the company on April 30, 2024
Julio Triana appointed to Board of Management of Bayer AG and President of the Consumer Health Division
February 29, 2024
Elections at the Annual Stockholders' Meeting on April 26, 2024:
Bayer aims to further extend expertise in Supervisory Board